Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. The energy crisis is leading to rising prices across the hydrocarbon complex and that is worrying market participants in all asset classes. In Europe the situation is particularly acute because of the high… Continue reading Why the Energy Crisis is the Midwife of Stagflation
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Manchester United shares are declining nearly 13% in pre-market action this morning in New York after the company announced that two members of the Glazer family – the soccer club’s owners – are… Continue reading Manchester United Shares Down 13% Today – Time to Buy MANU Shares?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. The price of Palantir stock is up 9% in pre-market stock trading action this morning following news that the company was awarded a contract from the United States Army Forces to deliver the… Continue reading Palantir Stock Up 9% Today – Time to Buy PLTR Stock?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. The healthcare sector is considered defensive in nature. As investors get wary of broader market valuations, here are some of the healthcare stocks that you can consider in October. Here we should note… Continue reading 5 Best Healthcare Stocks to Buy in October 2021
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. PepsiCo (PEP) stock rose 0.6% yesterday which took its YTD gains to 4.7%. Meanwhile, while the stock is underperforming the S&P 500 by a wide margin this year, it is outperforming rival Coca-Cola.… Continue reading PepsiCo Stock Price Forecast October 2021 – Time to Buy PEP Stock?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Popular ‘Dogecoin killer’ is getting a lot of media attention following its remarkable rally in the last 24 hours. With meme coins now becoming a mainstream concept, more investors are looking to buy… Continue reading Shiba Inu Price Up By 52.79% – Time to Buy SHIB Coin?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. The Tezos blockchain is an exciting crypto protocol. Given the popular Ethereum killer’s growing relevance in enabling the development of decentralized applications (dApps), thereby decentralized finance (DeFi) and non-fungible tokens (NFTs), more investors… Continue reading Tezos Price Down By 6.6% – Time to Buy XTZ Coin?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. The last few days has seen crypto bellwether Bitcoin making a push towards the $50K mark after a sub-par performance in September. With the crypto market getting renewed interests, more investors are out… Continue reading Bitcoin Price Up By 5.62% – Time To Buy BTC Coin?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Verb stock has gone up over 20% so far in October amid a sharp uptick the price experienced yesterday following news that the company suspended its agreement with Truist Securities to perform at-the-market… Continue reading Verb Stock Up 20% in October – Time to Buy VERB Stock?
Please note that we are not authorised to provide any investment advice. The content on this page is for information purposes only. Shares of U.S.-based insurance company, Lemonade (NYSE: LMND) have declined on seemingly no company-specific news. Many analysts have pointed out rising treasury yields as one of the main reasons why Lemonade shares have… Continue reading Lemonade Share Price Forecast October 2021 – Time to Buy LMND?